Our guest authors are Arun Venkatesan, MD, PhD, Associate Professor of Neurology and Scott Douglas Newsome, DO at the Johns Hopkins University School of Medicine.

After participating in this activity, the participant will demonstrate the ability to:

• Identify when patients with MS should start or switch disease modifying therapies.
• Recognize important clinical and paraclinical factors of disease activity in MS.
• Describe the factors that may play a role in non-adherence to MS treatment.

This discussion, offered as a downloadable audio file and companion transcript, covers the important topics of personalizing DMT regimens and the risk of medication non-adherence in the format of case-study scenarios for the clinical practice. This program is a follow up to the Volume 1, Issue 1 eMultipleSclerosis Review newsletter – Personalizing DMT Regimens/The Risks of Medication Non-Adherence.

Unlabeled/Unapproved Uses
Dr. Venkatesan and Dr. Newsome have indicated that there will be references to unlabeled/unapproved uses of drugs or products in today's discussion, including specifically rituximab, daclizumab, ocrelizumab, and anti-LINGO therapies.

	MEET THE AUTHORS
			Arun Venkatesan, MD, PhD Associate Professor of Neurology Director, Johns Hopkins Encephalitis Center Associate Program Director, Neurology Residency Johns Hopkins University School of Medicine Baltimore, Maryland
			Scott Douglas Newsome, DO Assistant Professor of Neurology Director, Neurology Outpatient Services Director, Neurology Infusion Center Johns Hopkins University School of Medicine

Guest Faculty Disclosure
Dr. Venkatesan has indicated that he has served as a consultant/advisor to MedImmune. Dr. Newsome has indicated that he has served as a consultant/advisor to Biogen, Genzyme, and Novartis, and that he has received grant/research funding from Biogen and Novartis.

Arun Venkatesan, MD, PhD
Associate Professor of Neurology
Director, Johns Hopkins Encephalitis Center
Associate Program Director, Neurology Residency
Johns Hopkins University School of Medicine
Baltimore, Maryland

Scott Douglas Newsome, DO
Scott Douglas Newsome, DO
Assistant Professor of Neurology
Director, Neurology Outpatient Services
Director, Neurology Infusion Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

All rights reserved - The Johns Hopkins University School of Medicine. Copyright 2015.

This activity was developed in collaboration with DKBmed.